Split Rock Partners Announces Josh Baltzell Promotion to Director and Relocation to Menlo Park
Jan 8, 2007 - Minneapolis, MN - Split Rock Partners, LLC ("Split Rock Partners") today announced that Josh Baltzell has been promoted to Director and will be relocating to the firm's Menlo Park office. He will continue to focus on new medical device opportunities.
Baltzell joined Split Rock Partners at the firm's inception as a Principal with the healthcare investment team. He currently serves as a Director on the boards of Emphasys Medical and Entellus, and is actively involved with the Firm's investments in Dexcom, Santarus, SkinMedica, Atritech and The Foundry.
"We are pleased to expand our presence in California through Josh's relocation to our Menlo Park office. Josh's blend of operating, banking and venture experience is consistent with our healthcare practice approach as active, value-added investors," said Allan Will, Split Rock Partners Managing Director.
Prior to the firm's inception in 2004, Baltzell served as Principal with St. Paul Venture Capital. Baltzell brings more than 13 years experience of venture capital and operating experience to the Split Rock Partners team. Prior to St. Paul Venture Capital, Baltzell was a Vice President in the healthcare investment banking group of Piper Jaffray. Earlier in his career, Baltzell held various marketing and business development positions in the medical device industry, most notably at SCIMED/Boston Scientific. Baltzell graduated with an M.B.A. degree from the University of Minnesota and holds a B.A. degree from St. Olaf College.
About Split Rock Partners
Split Rock Partners, with offices in Minneapolis and Menlo Park, seeks emerging opportunities in software, internet services and healthcare primarily in the Upper Midwest and West Coast. Split Rock Partners was formed in June 2004 by the software and healthcare investment teams of St. Paul Venture Capital and continues to manage St. Paul Venture Capital's existing software and healthcare portfolio. Representative healthcare companies in the Split Rock Portfolio include industry leaders such as Spine-Tech, The Foundry, Dexcom, Disc Dynamics, Emphasys Medical and XTENT. In May of 2005, the firm announced the closing of Split Rock Partners L.P, a $275 million venture fund. Additional information about Split Rock Partners can be found at www.splitrock.com.